Skip to main content
. 2022 Mar 11;4(2):e210067. doi: 10.1148/rycan.210067

Figure 2:

Axial images of (A) 68Ga-DOTATATE PET SUV50, (B) Patlak Ki, (C) three-dimensional T1-weighted post-gadolinium-enhanced MRI, (D) fused PET SUV/MRI T1, and (E) fused Patlak Ki/MRI T1 parameters in a 66-year-old woman in group A with a history of World Health Organization grade II meningioma status (same participant as in Fig 1). DOTATATE = tetraazacyclododecane tetraacetic acid octreotate, 68Ga = gallium 68, Ki = net binding rate constant, SUV = standardized uptake value, SUV50 = SUV extracted from the entire 50 minutes of acquisition.

Axial images of (A) 68 Ga-DOTATATE PET SUV50, (B) Patlak Ki, (C) three-dimensional T1-weighted post-gadolinium-enhanced MRI, (D) fused PET SUV/MRI T1, and (E) fused Patlak Ki/MRI T1 parameters in a 66-year-old woman in group A with a history of World Health Organization grade II meningioma status (same participant as in Fig 1). DOTATATE = tetraazacyclododecane tetraacetic acid octreotate, 68Ga = gallium 68, Ki = net binding rate constant, SUV = standardized uptake value, SUV50 = SUV extracted from the entire 50 minutes of acquisition.